New Hepatitis C Treatment for Children

New Hepatitis C Treatment for Children

It is now available a new and the first direct-acting antiviral hepatitis C virus (HCV) treatment for children and adolescents aged 12 to 17. It is the supplemental application for sofosbuvir (Sovaldi) and ledipasvir/sofosbuvir (Harvoni). According to Edward Cox, MD,...